Sam Park

Sam has more than 25 years of medical device start-up experience in design and operations building pre-revenue companies, and leading them through to acquisition.

Prior to joining Sight Sciences Inc., Sam served as VP of R&D and Operations at SurgRx where he led the development of EnSeal Vessel Sealing System which was purchased by Ethicon-Endo Surgery of J&J.

He also led operations at Novacept from early revenue to its acquisition by Cytyc. Sam has held various other executive and technical positions at Spineview (Expending Innovation), Arthrocare (acquired by Smith and Nephew), CardioGenesis (IPO), and Origin Medsystems (acquired by Eli Lily, later Guidant).

Before entering the medical device industry, Sam worked in aerospace at Hughes Aircraft, and Xerox Designing and Manufacturing Laser Systems.

Sam hold a BS from the University of California Irvine in Mechanical Engineering.